Adoptive immunotherapy in human and canine chimeras--the role of interferon alfa. EBMT Chronic Leukemia Working Party

Semin Hematol. 1993 Jul;30(3 Suppl 3):37-9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Chimera*
  • Dogs
  • Female
  • Graft vs Host Disease / complications
  • Graft vs Host Disease / therapy*
  • Humans
  • Immunotherapy, Adoptive*
  • Interferon-alpha / therapeutic use*
  • Leukemia / complications
  • Leukemia / therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Lymphocyte Transfusion
  • Lymphoma / complications
  • Lymphoma / therapy
  • Male
  • Multiple Myeloma / complications
  • Multiple Myeloma / therapy
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / therapy
  • Primary Myelofibrosis / complications
  • Primary Myelofibrosis / therapy

Substances

  • Interferon-alpha